The state of cancer care in Russia: cancer of the small intestine (C17). morbidity, mortality, index of accuracy, annual mortality (population study at the federal district level). Part I

Relevance. Small intestine cancer is extremely rare cancer among the Russian population with the incidence of less than 1 per 100,000 populations. in 2019, 1,643 cases of small intestine cancer were recorded in Russia, including 750 cases among the male population, and 893 among the female population. only since 2011 state statistics provides for the inclusion of primary cases of small intestine in a separate line in the state report form № 7. in 2019, none of the small intestine cancer cases was registered in four administrative territories of Russia, and only one case was registered in 13territories among the female population. in the North-Western Federal district (NWFD) of the Russian Federation, 187 primary cases of small intestine cancer were diagnosed in 2019; the standardized incidence rates were 0.91 and 0.57 0/0000 for men and women, respectively. more than 1,200 people die from small intestine cancer annually in Russia, and approximately 130 people die from this cancer in the Northwestern Federal district of the Russian Federation. the standardized mortality rates among the population of Russia and the Northwestern Federal district of the Russian Federation for men and women are 54 and 0.58 per 100,000 and 0.33 and 0.37 per 100,000, respectively. The purpose of the study was to analyze small intestine cancer incidence and mortality rates in the population of Russia. Material and methods. The population-based cancer registries of IARC, P.A. Herzen institute of oncology, N.N. Petrov Research institute of oncology as well as the population-based cancer registries of the Northwestern Federal District of the Russian Federation were used. Standard methods of oncology statistics were used. Results. the study, for the first time in Russia, made it possible to estimate the prevalence of small intestine cancer, which is much less common in Russia than in the USA and in other economically developed countries. Conclusion. In females, a significant decrease in standardized mortality rates of small intestine cancer was revealed. in males, this rate remained almost unchanged. a positive dynamics of annual mortality rates, especially within the first year of follow-up, was found.

1. International statistical classification of diseases and health-related problems (ICD-10). WHO. Geneva, 1995. 698 p. (in Russian).

2. Merabishvili V.M. Malignant tumors of the heart – a rare but dangerous tumor (based on the materials of the North-Western Federal District of Russia). Formulas of Formation. 2020. 2(3): 30–9. (in Russian).

3. Merabishvili V.M., Merabishvili E.N. The Prevalence of Malignant Tumors of the Eye and Adnexa (C69). Ophthalmology. 2020; (3): 495–501. (in Russian).

4. Albom A., Norell S. Introduction to modern epidemiology. Tallinn, 1996. 122 p. (in Russian).

5. Merabishvili V.M. Malignant tumors in the North-West Federal Region of Russia (morbidity, mortality, index accuracy, survival). Express-information. Fifth Issue. St. Petersburg, 2020. 236 p. (in Russian).

6. The state of cancerl care in Russia in 2020. Ed. by A.D. Kaprin, V.V. Starinsky, A.O. Shakhzadova. Moscow, 2021. 239 p. (in Russian).

7. Characteristics and methods of calculating statistical rates used in oncology. Practical guide. M., 2005. 43 p. (in Russian).

8. Malignant tumors in Russia in 2019 (morbidity and mortality). Ed. by A.D. Kaprina, V.V. Starinskogo, G.V. Petrovoi. Moscow, 2020. 214 p. (in Russian).

9. Cancer Incidence in Five Continents. Volume XI. IARC. Cancer-Base. № 14. Lyon, 2018.

10. Malignant neoplasms in Russia in 2020 (morbidity and mortality). Ed. by A.D. Kaprin, V.V. Starinsky, A.O. Shakhzadova. Moscow, 2021. 252 p. (in Russian).

11. Malignant tumors in Russia in 2010 (morbidity and mortality). Moscow, 2012. 260 p. (in Russian).

12. Malignant tumors in Russia in 2015 (morbidity and mortality). Moscow, 2016. 250 p. (in Russian).

13. Malignant tumors in Russia in 2016 (morbidity and mortality). Moscow, 2017. 250 p. (in Russian).

14. Malignant tumors in Russia in 2017 (morbidity and mortality). Moscow, 2018. 250 p. (in Russian).

15. Malignant tumors in Russia in 2018 (morbidity and mortality). Moscow, 2019. 250 p. (in Russian).

16. Merabishvili V.M. Analytical indicators of index of accuracy. Problems in Oncology. 2018. 64(3): 445–52. (in Russian).

17. Merabishvili V.M. Index of accuracy – the main criteria for an objective assessment of the activity of the oncological service for all localities of malignant tumors, regardless of the level of lethality of patients. Problems in Oncology. 2019. 65(4): 510–5. (in Russian).

18. Merabishvili V.M. Oncology statistics (traditional methods, new information technologies): a guide for doctors. Part I. St. Petersburg, 2011. 221 p. (in Russian).

19. Cancer registration. Principles and methods. Tallinn, 1997. 95 с. (in Russian).

20. Demographic yearbook of Russia. 2005: Moscow, 2005. 595 p. (in Russian).

21. Demographic yearbook of Russia. 2015. Moscow, 2015. 264 p. (in Russian).

22. Healthcare in Russia, 2015. Moscow, 2007. 174 p. (in Russian).

23. Demographic yearbook of Russia. 2016. Moscow, 2016. (in Russian).

24. Cancer incidence in the USSR. № 48. Second Revised Edition. Lyon: IARC, 1983.

25. Segi M. Cancer mortality for selected sities in 24 countries (1950–1957). Japan: Department of Public Health, Tohoku University of Medicine, 1960.